New Zealand markets closed

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
175.27+6.07 (+3.59%)
At close: 04:00PM EDT
175.50 +0.23 (+0.13%)
After hours: 07:59PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
54,403,000
54,318,000
58,054,000
56,197,000
45,804,000
Cost of revenue
20,523,000
20,415,000
17,414,000
17,446,000
15,387,000
Gross profit
33,880,000
33,903,000
40,640,000
38,751,000
30,417,000
Operating expenses
Research development
7,322,000
7,675,000
6,510,000
6,922,000
6,379,000
Selling general and administrative
13,148,000
12,872,000
15,260,000
12,349,000
11,299,000
Total operating expenses
20,301,000
20,368,000
21,826,000
19,703,000
17,678,000
Operating income or loss
13,579,000
13,535,000
18,814,000
19,048,000
12,739,000
Interest expense
2,331,000
2,224,000
2,230,000
2,423,000
2,454,000
Total other income/expenses net
-4,366,000
-5,601,000
-3,293,000
-3,675,000
-7,061,000
Income before tax
7,530,000
6,250,000
13,477,000
12,989,000
3,398,000
Income tax expense
1,526,000
1,377,000
1,632,000
1,440,000
-1,224,000
Income from continuing operations
6,004,000
4,873,000
11,845,000
11,549,000
4,622,000
Net income
5,993,000
4,863,000
11,836,000
11,542,000
4,616,000
Net income available to common shareholders
5,951,000
4,820,000
11,782,000
11,468,000
4,556,000
Basic EPS
3.66
2.75
6.69
6.53
2.62
Diluted EPS
3.65
2.72
6.63
6.45
2.62
Basic average shares
1,768,750
1,765,941
1,769,181
1,768,338
1,765,133
Diluted average shares
1,774,250
1,773,000
1,778,000
1,777,000
1,765,133